Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News, archive: February 2019

2/1/2019 Database Update: API Import to Russia (December 2018)

In 2018, Russia imported 96.5 bln RUB worth of APIs (free circulation prices, VAT included), which is in monetary terms 30.6% higher than that in 2017. However, the dynamics are that high mostly due to higher import prices. In physical terms, the dynamics are -3% (11,900 tons.)

2/1/2019 Database Update: Pharmaceutical Drug Import to Russia (December 2018)

In 2018, Russia imported 531 bln RUB worth of ready-made pharmaceutical drugs (free circulation prices), which is in monetary terms only 1.1% higher than that in 2017, and 105.4 bln RUB worth o in-bulk pharmaceuticals, which is in monetary terms 10.3% higher than that in 2017. Despite the high dynamics of the in-bulk import, the import volume is much lower than that in 2016, when it was 111 bln RUB.